When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously ...

Eli Lilly has firmed up the label for its type 2 diabetes therapy Trulicity with FDA approval for a new cardiovascular risk reduction claim, as it faces increased competition from Novo Nordisk.

Eli Lilly’s crop of new products ... and $28 million for Novartis in the same period. Trulicity’s performance was a big positive for Lilly however, as there had been speculation that it ...

you may be eligible to pay as low as $25 for a one- or three-month supply of Zepbound,” Eli Lilly says. “One month is defined as 28 days and 4 pens. Three months is defined as 84 days and up ...